Skip to main content

Table 1 Dataset characteristics – demographic and cancer subtype distribution in each risk category for the cases from the 3 different institutions considered in this study

From: Quantitative nuclear histomorphometry predicts oncotype DX risk categories for early stage ER+ breast cancer

Parameters

   

Oncotype DX Risk Category

Low (< 18)

Intermediate (> 18, ≤30)

High(> 30)

No. of Patients (N = 125)

66 (53%)

44 (35%)

15 (12%)

Age

20–77

25–70

45–70

Sex

 Female

66 (53%)

43 (34%)

15 (12%)

 Male

0 (0%)

1 (1%)

0 (0%)

Patient Ethnicity

 White

33 (26%)

23 (18%)

5 (5%)

 African American

3 (2%)

2 (2%)

2 (2%)

 Asian

1 (1%)

2 (2%)

1 (1%)

 Unknown

22 (18%)

17 (14%)

7(6%)

PR Status

 Positive

64 (51%)

39 (31%)

10 (8%)

 Negative

2 (2%)

3 (2%)

5 (4%)

 Unknown

0 (0%)

2 (2%)

0 (0%)

HER2 Status

 Positive

0 (0%)

1 (1%)

0 (0%)

 Negative

66 (53%)

42 (34%)

15 (12%)

 Unknown

0 (0%)

1 (1%)

0 (0%)

Histologic Tumor Grade

 Low (4, 5)

10 (8%)

14 (11%)

0 (0%)

 Moderate (6, 7)

48 (38%)

24 (19%)

4 (3%)

 High (8, 9)

8 (6%)

6 (5%)

11 (9%)

Tumor Type

 Ductal

53 (42%)

37 (30%)

14 (11%)

 Ductal With Lobular Features

9 (7%)

3 (2%)

1 (1%)

 Ductal with Mucinous Features

1 (1%)

2 (2%)

0 (0%)

 Mixed

3 (2%)

2 (2%)

0 (0%)